This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a market structure of monopoly? a. Few firms operating as price takers. ... (Read 32 times)

silviawilliams41

  • Hero Member
  • *****
  • Posts: 560
Which of the following is a market structure of monopoly?
 a. Few firms operating as price takers.
  b. Single firm operating as a price taker.
  c. Single firm that is a price maker.
  d. All of these are true.

Question 2

The amount by which an additional unit of a good or service increases a consumer's total utility is:
 a. marginal bliss.
  b. marginal benefit.
  c. marginal utility.
  d. marginal.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

harveenkau8139

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

c

Answer to Question 2

c




silviawilliams41

  • Member
  • Posts: 560
Reply 2 on: Jun 30, 2018
Great answer, keep it coming :)


LegendaryAnswers

  • Member
  • Posts: 341
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library